AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.00644-06v1
50/11/3724    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ge, Q.
Right arrow Articles by Stein, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ge, Q.
Right arrow Articles by Stein, D. A.
Antimicrobial Agents and Chemotherapy, November 2006, p. 3724-3733, Vol. 50, No. 11
0066-4804/06/$08.00+0     doi:10.1128/AAC.00644-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Inhibition of Multiple Subtypes of Influenza A Virus in Cell Cultures with Morpholino Oligomers{triangledown}

Qing Ge,1,{dagger} Manoj Pastey,2,{dagger} Darwyn Kobasa,3,{dagger} Piliapan Puthavathana,4 Christopher Lupfer,2 Richard K. Bestwick,5 Patrick L. Iversen,5 Jianzhu Chen,1 and David A. Stein5*

Center for Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139,1 Department of Biomedical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, Oregon 97331,2 Public Health Agency of Canada, Winnipeg, Manitoba, Canada,3 Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand,4 AVI BioPharma Inc., Corvallis, Oregon 973335

Received 25 May 2006/ Returned for modification 7 July 2006/ Accepted 19 August 2006

Peptide-conjugated phosphorodiamidate morpholino oligomers (P-PMO) are single-stranded nucleic acid-like antisense agents that can reduce gene expression by sterically blocking complementary RNA sequence. P-PMO are water soluble and nuclease resistant, and they readily achieve uptake into cells in culture under standard conditions. Eight P-PMO, each 20 to 22 bases in length, were evaluated for their ability to inhibit influenza A virus (FLUAV) A/PR/8/34 (H1N1) replication in cell culture. The P-PMO were designed to base pair with FLUAV RNA sequences that are highly conserved across viral subtypes and considered critical to the FLUAV biological-cycle, such as gene segment termini and mRNA translation start site regions. Several P-PMO were highly efficacious, each reducing viral titer in a dose-responsive and sequence-specific manner in A/PR/8/34-infected cells. Two P-PMO, one designed to target the AUG translation start site region of PB1 mRNA and the other the 3'-terminal region of nucleoprotein viral genome RNA, also proved to be potent against several other FLUAV strains, including A/WSN/33 (H1N1), A/Memphis/8/88 (H3N2), A/Eq/Miami/63 (H3N8), A/Eq/Prague/56 (H7N7), and the highly pathogenic A/Thailand/1(KAN-1)/04 (H5N1). The P-PMO exhibited minimal cytotoxicity in cell viability assays. High efficacy by two of the P-PMO against multiple FLUAV subtypes suggests that these oligomers represent a broad-spectrum therapeutic approach against a high percentage of known FLUAV strains.


* Corresponding author. Mailing address: AVI BioPharma Inc., 4575 SW Research Way, Corvallis, OR 97333. Phone: (541) 753-3635. Fax: (541) 754-3545. E-mail: steind{at}avibio.com.

{triangledown} Published ahead of print on 11 September 2006.

{dagger} These authors contributed equally to this work.


Antimicrobial Agents and Chemotherapy, November 2006, p. 3724-3733, Vol. 50, No. 11
0066-4804/06/$08.00+0     doi:10.1128/AAC.00644-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.